PDT Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
PDT Partners's ROIV Position: Q3 2026 in Review
PDT Partners sold out of Roivant Sciences (ROIV) in Q3 2026, closing a stake of 108,100 shares — an estimated $3.83M sold.
PDT Partners first reported a position in ROIV in Q1 2023 and held it in 12 quarters. The position peaked at $10.4M in Q1 2026. 505 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- PDT Partners reported no remaining Roivant Sciences position as of Q3 2026 after selling out during the quarter.
- PDT Partners sold 108,100 Roivant Sciences shares in Q3 2026, an estimated $3.83M.
- PDT Partners first reported a position in Roivant Sciences in Q1 2023 and held it in 12 quarters.
- PDT Partners's Roivant Sciences position peaked at $10.4M in Q1 2026.
- 505 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on PDT Partners's 13F filing for Q3 2026, filed 16 Nov 2026.